Thymic carcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who underwent surgery for thymic carcinoma at Okayama University Hospital or collaborating institutions between January 2010 and December 2021. 2. Patients aged 20 years or older at the time of surgery. 3. Sex: male or female. 4. Inpatient or outpatient status.
Exclusion criteria
Exclusion criteria: 1. Patients with insufficient remaining clinical or pathological data for analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between tumor-infiltrating lymphocytes (TILs), tertiary lymphoid structures (TLSs), and peripheral blood-derived biomarkers (NLR, PLR, LMR, PNI, and mGPS) using surgical tissue specimens, and postoperative survival in patients with thymic carcinoma. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of postoperative recurrence, cause-specific mortality, recurrence-free survival (RFS), and progression-free survival (PFS). Analysis of overall survival and recurrence-free survival stratified by surgical procedure. | — |
Countries
Japan
Contacts
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Department of General Thoracic Surgery and Breast and Endocrinological Surgery